Physician profile
Amy L Illescas
NPI 1346269123
$19,952.10
in general payments reported to CMS, 2019-2025
80 companies · $2,964 in 2025
The $2,964 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,271 · 2020: $2,380 · 2021: $2,879 · 2022: $2,893 · 2023: $3,193 · 2024: $3,372 · 2025: $2,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,529.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,943.92 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,972.89 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $1,832.84 | 2020-2025 | |
| Pfizer INC. | $1,142.00 | 2019-2025 | |
| Dexcom, INC. | $1,065.99 | 2021-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $1,039.06 | 2019-2025 | Otezla, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $901.30 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $759.54 | 2019-2025 | Trintellix |
| Allergan, INC. | $589.80 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $584.80 | 2019-2024 | Farxiga, Airsupra |
| Exact Sciences Corporation | $411.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $400.46 | 2019-2025 | Xifaxan |
| Antares Pharma, INC. | $382.73 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Intra-Sana Laboratories | $276.59 | 2024-2025 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Merck Sharp & Dohme LLC | $275.64 | 2019-2022 |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $255.99 | 2020-2024 | Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.05 | 2019-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $247.40 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $192.60 | 2022-2025 | Rexulti |
| Vivus LLC | $191.17 | 2019-2022 | |
| Upsher-Smith Laboratories LLC | $186.91 | 2020-2023 | |
| Neos Therapeutics, LP | $182.06 | 2019-2024 | Adzenys Xr-Odt |
| Janssen Pharmaceuticals, INC | $172.01 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $150.86 | 2023-2025 | Veozah, Myrbetriq |
| Phathom Pharmaceuticals, INC. | $147.73 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $144.92 | 2019-2021 | |
| Ardelyx, INC. | $139.83 | 2024-2025 | Ibsrela |
| Lundbeck LLC | $122.88 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $98.57 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Shield Therapeutics INC | $97.02 | 2022-2025 | Accrufer |
| Halozyme INC | $93.66 | 2023 | |
| Glaxosmithkline, LLC. | $91.58 | 2021-2024 | Trelegy Ellipta |
| Esperion Therapeutics, INC. | $90.11 | 2020-2022 | |
| Abbott Laboratories | $83.23 | 2019-2024 | Freestyle Libre |
| Corium, LLC | $69.23 | 2023 | Azstarys |
| Hologic Sales and Service, LLC | $69.14 | 2021-2024 | Aptima |
| Supernus Pharmaceuticals, INC. | $65.27 | 2019-2023 | Tlando, Xyosted, Qelbree |
| Genentech USA, INC. | $63.37 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $63.11 | 2022-2024 | Quviviq |
| Nabriva Therapeutics, Plc | $62.58 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $57.52 | 2020-2021 | |
| Almatica Pharma LLC | $56.69 | 2023-2024 | Loreev Xr, Gralise |
| Eisai INC. | $56.52 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $49.50 | 2024-2025 | Caplyta |
| Beta Bionics, INC. | $45.91 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sanofi-Aventis U.S. LLC | $41.00 | 2022-2025 | |
| Tolmar, INC. | $40.60 | 2023-2025 | Jatenzo |
| Verity Pharmaceuticals INC. | $38.61 | 2024-2025 | Tlando |
| Neurocrine Biosciences, INC. | $37.95 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $35.62 | 2019 | |
| Ibsa Pharma INC. | $33.96 | 2020-2025 | Flector, Licart, Tirosint |
| Collegium Pharmaceutical, INC. | $29.86 | 2022-2025 | Jornay Pm |
| Axsome Therapeutics, INC. | $29.53 | 2023 | Auvelity |
| Currax Pharmaceuticals LLC | $28.54 | 2023-2025 | Contrave, Onzetra Xsail, Nexletol |
| Assertio Therapeutics, INC. | $27.42 | 2020 | |
| Boston Scientific Corporation | $27.17 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $24.30 | 2023 | Evkeeza |
| Mannkind Corporation | $23.98 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.93 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $23.15 | 2020 | |
| Alexion Pharmaceuticals, INC. | $21.33 | 2023 | Strensiq |
| Inari Medical, INC. | $21.13 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Siemens Medical Solutions USA, INC. | $21.00 | 2025 | Immulite 1000 Immunoassay System |
| Noven Therapeutics, LLC | $19.78 | 2024 | Xelstrym |
| Corcept Therapeutics | $18.65 | 2023 | Korlym |
| Novartis Pharmaceuticals Corporation | $18.59 | 2023 | |
| Tandem Diabetes Care, INC. | $17.76 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Daiichi Sankyo INC. | $15.25 | 2019 | |
| Shire North American Group INC | $14.44 | 2019 | |
| Medtronic, INC. | $14.26 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.26 | 2024 | |
| Optinose US, INC. | $14.22 | 2024 | |
| Redhill Biopharma INC. | $13.72 | 2021 | |
| Viiv Healthcare Company | $13.11 | 2022 | |
| Tris Pharma INC | $12.80 | 2022 | |
| Amneal Pharmaceuticals LLC | $12.45 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.70 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.16 | 2020 | |
| Avion Pharmaceuticals | $10.96 | 2019 | |
| Aytu Biopharma, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Illescas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.